2268 — WuXi XDC Cayman Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeLarge CapHigh Flyer

Annual income statement for WuXi XDC Cayman, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	96.4	311	990	2,124	4,052
Cost of Revenue
Gross Profit	8.08	113	261	560	1,240
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	64	244	792	1,763	2,829
Operating Profit	32.4	67.3	199	360	1,223
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	32.4	66.9	196	360	1,220
Provision for Income Taxes
Net Income After Taxes	26.3	54.9	156	284	1,070
Net Income Before Extraordinary Items
Net Income	26.3	54.9	156	284	1,070
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	26.3	54.9	156	284	1,070
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.022	0.047	0.132	0.303	0.831